Journal ArticleDOI
Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation.
Reads0
Chats0
TLDR
The burden of coronary artery disease among kidney and liver transplant candidates is addressed and the literature pertaining to the diagnostic accuracy and the prognostic value of noninvasive cardiac imaging techniques in this population is reviewed.About:
This article is published in Journal of Nuclear Cardiology.The article was published on 2021-03-05. It has received 30 citations till now. The article focuses on the topics: Cardiac Imaging Techniques & Liver transplantation.read more
Citations
More filters
Journal ArticleDOI
Evaluation of coronary artery disease in potential liver transplant recipients.
TL;DR: In assessing LT recipients, a management paradigm of “quadruple assessment” is suggested to include (1) history, examination, and electrocardiogram; (2) transthoracic echocardiograms; (3) functional testing; and (4) where appropriate, direct assessment of CAD.
Journal ArticleDOI
The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease
TL;DR: Regadenoson-stress SPECT-MPI provides a significant prognostic value in patients with end-stage renal disease (ESRD) and is associated with increased rate of the composite endpoint of cardiac death, MI, or CR.
Journal ArticleDOI
The diagnostic and prognostic utility of risk factors defined by the AHA/ACCF on the evaluation of cardiac disease in liver transplantation candidates.
TL;DR: Having ≥3 AHA/ACCF risk factors is a reasonable threshold to prompt non-invasive stress testing in asymptomatic liver transplantation candidates, and provides significant diagnostic and prognostic utility.
Journal ArticleDOI
Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease
Wael AlJaroudi,Tania Campagnoli,Ibtihaj Fughhi,Marwan Wassouf,Amjad Ali,Rami Doukky,Rami Doukky +6 more
TL;DR: Blunted HRR (<28%) to regadenoson is a strong and independent predictor of death and cardiovascular events in patients with ESRD and adds incremental prognostic value.
References
More filters
Journal ArticleDOI
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
TL;DR: The longitudinal glomerular filtration rate was estimated among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation.
Journal ArticleDOI
Inflammation, Atherosclerosis, and Coronary Artery Disease
TL;DR: The evidence is recounted that atherosclerosis, the main cause of CAD, is an inflammatory disease in which immune mechanisms interact with metabolic risk factors to initiate, propagate, and activate lesions in the arterial tree.
Journal ArticleDOI
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
Mark J. Sarnak,Andrew S. Levey,Anton C. Schoolwerth,Josef Coresh,Bruce F. Culleton,L. Lee Hamm,Peter A. McCullough,Bertram L. Kasiske,Ellie Kelepouris,Michael J. Klag,Patrick S. Parfrey,Marc A. Pfeffer,Leopoldo Raij,David J. Spinosa,Peter W.F. Wilson +14 more
TL;DR: There was a high prevalence of CVD in CKD and that mortality due to CVD was 10 to 30 times higher in dialysis patients than in the general population, and the task force recommended that patients with CKD be considered in the “highest risk group” for subsequent CVD events.
Journal ArticleDOI
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention
Bernard De Bruyne,Uwe Siebert,Fumiaki Ikeno,Volker Klauss,Ganesh Manoharan,Thomas Engstrøm,Keith G. Oldroyd,Peter N. Ver Lee,Philip MacCarthy,William F. Fearon +9 more
TL;DR: Routine measurement of FFR in patients with multivessel coronary artery disease who are undergoing PCI with drug-eluting stents significantly reduces the rate of the composite end point of death, nonfatal myocardial infarction, and repeat revascularization at 1 year.
Journal ArticleDOI
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
Rajiv Saran,Bruce M. Robinson,Kevin C. Abbott,Lawrence Y. Agodoa,Patrick Albertus,John Z. Ayanian,Rajesh Balkrishnan,Jennifer L. Bragg-Gresham,Jie Cao,Joline L.T. Chen,Elizabeth Cope,Sai Dharmarajan,Xue Dietrich,Ashley Eckard,Paul W. Eggers,Charles Gaber,Daniel L. Gillen,Debbie S. Gipson,Haoyu Gu,Susan M. Hailpern,Yoshio N. Hall,Yun Han,Kevin He,Paul C. Hébert,Margaret E. Helmuth,William H. Herman,Michael Heung,David W. Hutton,Steven J. Jacobsen,Nan Ji,Yan Jin,Kamyar Kalantar-Zadeh,Alissa Kapke,Ronit Katz,Csaba P. Kovesdy,Vivian Kurtz,Danielle Lavallee,Yi Li,Yee Lu,Keith McCullough,Miklos Z. Molnar,Maria E. Montez-Rath,Hal Morgenstern,Qiao Mu,Purna Mukhopadhyay,Brahmajee K. Nallamothu,Danh V. Nguyen,Keith C. Norris,Ann M. O’Hare,Yoshitsugu Obi,Jeffrey Pearson,Ronald L. Pisoni,Brett Plattner,Friedrich K. Port,Praveen K. Potukuchi,Panduranga S. Rao,Kaitlyn Ratkowiak,Vanessa A. Ravel,Debabrata Ray,Connie M. Rhee,Douglas E. Schaubel,David T. Selewski,Sally F. Shaw,Jiaxiao Shi,Monica Shieu,John J. Sim,Peter X.-K. Song,Melissa Soohoo,Diane Steffick,Elani Streja,Manjula Kurella Tamura,Francesca Tentori,Anca Tilea,Lan Tong,Megan Turf,Dongyu Wang,Mia Wang,Kenneth J. Woodside,April Wyncott,Xin Xin,Wei Zeng,Lindsay Zepel,Sai Zhang,Hui Zho,Richard A. Hirth,Vahakn Shahinian +85 more
TL;DR: Author(s): Saran, Rajiv; Robinson, Bruce; Abbott, Kevin C; Agodoa, Lawrence YC; Ayanian, John; Balkrishnan, Rajesh; Bragg-Gresham, Jennifer; Cao, Jie; Chen, Joline LT; Cope, Elizabeth; Dharmarajan, Sai; Dietrich, Xue; Eckard, Ashley; Eggers, Paul W; Gaber, Charles; Gillen, Daniel;